Technical Analysis for VXRT - Vaxart, Inc.

Grade Last Price % Change Price Change
F 1.00 -6.54% -0.07
VXRT closed down 6.54 percent on Wednesday, February 8, 2023, on 44 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: Feb 22
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Below Lower BB Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish -6.54%
Crossed Above 50 DMA Bullish -6.54%
Lizard Bullish Bullish Day Trade Setup -6.54%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 7 hours ago
Lower Bollinger Band Support about 7 hours ago
Fell Below Previous Day's Low about 10 hours ago
Fell Below Lower Bollinger Band about 10 hours ago
60 Minute Opening Range Breakdown about 10 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Influenza Vaccines Coronavirus Vaccination Hepatitis B Papillomavirus Seasonal Influenza HPV Human Papilloma Virus

Is VXRT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.43
52 Week Low 0.7316
Average Volume 3,152,840
200-Day Moving Average 2.50
50-Day Moving Average 1.06
20-Day Moving Average 1.10
10-Day Moving Average 1.08
Average True Range 0.08
RSI 42.20
ADX 19.82
+DI 19.00
-DI 16.10
Chandelier Exit (Long, 3 ATRs) 1.01
Chandelier Exit (Short, 3 ATRs) 1.22
Upper Bollinger Bands 1.20
Lower Bollinger Band 1.00
Percent B (%b) 0.0
BandWidth 17.90
MACD Line -0.01
MACD Signal Line 0.00
MACD Histogram -0.0048
Fundamentals Value
Market Cap 109.47 Million
Num Shares 109 Million
EPS -2.03
Price-to-Earnings (P/E) Ratio -0.49
Price-to-Sales 67.33
Price-to-Book 5.84
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.11
Resistance 3 (R3) 1.12 1.09 1.09
Resistance 2 (R2) 1.09 1.07 1.09 1.08
Resistance 1 (R1) 1.05 1.05 1.04 1.04 1.08
Pivot Point 1.02 1.02 1.02 1.02 1.02
Support 1 (S1) 0.98 1.00 0.97 0.97 0.92
Support 2 (S2) 0.95 0.98 0.95 0.92
Support 3 (S3) 0.91 0.95 0.91
Support 4 (S4) 0.90